Immunothérapie 2.0
Description
L'immunothérapie prend sa place au coeur des thérapeutiques anti-cancéreuses avec des applications de plus en plus larges, un succès grandissant porté par des résultats inespérés. Eric Vivier nous présente les résultats très prometteurs de ses -cutting-edge- recherches dans ce domaine.
Eric Vivier is a professor of immunology at Aix-Marseille Université.
He graduated in veterinary medicine at the Ecole vétérinaire of Maisons-Alfort, and holds a Ph. D in immunology from Université Paris XI. He has been a postdoctoral fellow at Harvard Medical School, before joining the Centre d’Immunologie de Marseille-Luminy (CIML) as a professor. He is the director of the CIML since 2008.
In 1999 he co-founded the biotech company Innate-Pharma, then Marseille-Immunopôle, a cluster combining primary research, therapeutics, innovation and industrial development in the Aix-Marseille area.
Eric Vivier’s works focus on immunology and more specifically on ontogenesis, on therapeutic functions and manipulations of natural killer cells (NK) and innate lymphoïd cells (ILCs) in mice and in humans.
He is the author of over 300 scientific publications, and the recipient of numerous national and international awards for his outstanding work. Eric Vivier is a senior member of the French Academie des Sciences and has been recently elected at the Académie Nationale de Médecine.
This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx
Eric Vivier is a professor of immunology at Aix-Marseille Université.
He graduated in veterinary medicine at the Ecole vétérinaire of Maisons-Alfort, and holds a Ph. D in immunology from Université Paris XI. He has been a postdoctoral fellow at Harvard Medical School, before joining the Centre d’Immunologie de Marseille-Luminy (CIML) as a professor. He is the director of the CIML since 2008.
In 1999 he co-founded the biotech company Innate-Pharma, then Marseille-Immunopôle, a cluster combining primary research, therapeutics, innovation and industrial development in the Aix-Marseille area.
Eric Vivier’s works focus on immunology and more specifically on ontogenesis, on therapeutic functions and manipulations of natural killer cells (NK) and innate lymphoïd cells (ILCs) in mice and in humans.
He is the author of over 300 scientific publications, and the recipient of numerous national and international awards for his outstanding work. Eric Vivier is a senior member of the French Academie des Sciences and has been recently elected at the Académie Nationale de Médecine.
This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx
Événement TEDx
TEDx Aix 2017Thématiques
Proposer une thématique
Cette conférence devrait-elle apparaître dans d'autres thématiques ? Cochez une ou plusieurs cases. Votre suggestion sera vérifiée avant publication (pas de compte requis).